Mackenzie Financial
BLUE

Mackenzie Financial’s bluebird bio BLUE Stock Holding History

Mackenzie Financial’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-801
Closed -$1.51M – 1146
2018
Q3 		$1.51M Buy
+801
New +$1.65M ﹤0.01% 692
2018
Q2 		– Sell
-124
Closed -$274K – 1006
2018
Q1 		$274K Buy
+124
New +$315K ﹤0.01% 826

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial's BLUE Position: Q4 2018 in Review

Mackenzie Financial sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 801 shares — an estimated $1.51M sold.

Mackenzie Financial first reported a position in BLUE in Q1 2018 and held it in 2 quarters. The position peaked at $1.51M in Q3 2018. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.

  • Mackenzie Financial reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
  • Mackenzie Financial sold 801 bluebird bio shares in Q4 2018, an estimated $1.51M.
  • Mackenzie Financial first reported a position in bluebird bio in Q1 2018 and held it in 2 quarters.
  • Mackenzie Financial's bluebird bio position peaked at $1.51M in Q3 2018.
  • 251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.

Based on Mackenzie Financial's 13F filing for Q4 2018, filed 6 Feb 2019.